Clinical Practice Guidelines

CSPT is endorsing relevant clinical practice guidelines. "Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy" is posted below. 

Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy

 

Members are asked to review this document and send your comments directly to Dr. Bruce Carleton via email: bcarleton@popi.ubc.ca by May 1, 2017.

 

 


CSPT Endorsed Publications

 

Clinical Practice Guideline: CYP2D6 Genotyping for Safe and Efficacious Codeine Therapy
    Recommendations forHLA-B*15:02 andHLA-A*31:01genetic testing to reduce the risk of carbamazepine induced hypersensitivity reactions
      Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers
        Pharmacogenomic Declaration